UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy

Diseases of the colon & rectum, 2007-06, Vol.50 (6), p.825-831

2007

Volltextzugriff (PDF)

T1141 Co-Administration of Certolizumab Pegol with Immunosuppressants and/or Corticosteroids Is Not Associated with An Increased Risk of Adverse Events with Crohn's Disease: Analysis of Pooled Data

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-493-A-493

2008

Volltextzugriff (PDF)

488 Early Institution of Tinidazole May Prevent Pouchitis Following Ileal-Pouch Anal Anastomosis (IPAA) Surgery in Ulcerative Colitis (UC) Patients

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-69-S-69

2010

Volltextzugriff (PDF)

W1105 Cyclosporine and Infliximab As Delayed Salvage Therapy for Each Other in Patients with Steroid-Refractory Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-655-A-655

2009

Volltextzugriff (PDF)

M1136 The Natural History of Dysplasia in Inflammatory Bowel Disease: Influence of Disease Type and Dysplasia Morphology and Grade On Cancer Risk

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-346-A-346

2008

Volltextzugriff (PDF)

Infliximab therapy for ulcerative colitis: many unanswered questions

The American journal of gastroenterology, 2001, Vol.96 (8), p.2294-2296

Present, Daniel H

2001

Volltextzugriff (PDF)

Preliminary report: cyclosporin in treatment of severe active ulcerative colitis

The Lancet (British edition), 1990-07, Vol.336 (8706), p.16-19

1990

Volltextzugriff (PDF)

T1062 Improvement in Work Productivity with Adalimumab in Crohn's Disease Patients Who Failed Prior Infliximab: An Analysis of the CHOICE Trial

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-475-A-475

2008

Volltextzugriff (PDF)

T1061 Improvement in Short Inflammatory Bowel Disease Questionnaire Scores in Adalimumab-Treated Crohn's Disease Patients Who Failed Infliximab (CHOICE Trial)

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-474-A-475

2008

Volltextzugriff (PDF)

Urinary tract fistulas in Crohn’s disease: surgery versus medical therapy

The American journal of gastroenterology, 2002, Vol.97 (9), p.2165-2167

Present, Daniel H

2002

Volltextzugriff (PDF)

Alcohol is well tolerated in IBD patients taking either metronidazole or 6-Mercaptopurine

The American journal of gastroenterology, 2003-09, Vol.98 (s9), p.S241-S241

2003

Volltextzugriff (PDF)

1047 Chromoendoscopy Is Superior to Standard Surveillance Techniques for Both High and Low Risk Patients for the Detection of Dysplasia: Analysis of a Prospective Controlled Trial

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-160-A-160

2009

Volltextzugriff (PDF)

558 Outcomes After Retreatment with Cyclosporine a (CsA) in Hospitalized Ulcerative Colitis (UC) Patients: A 7-Year Review from a Single Institution

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-87-A-87

2009

Volltextzugriff (PDF)

557 Colectomy Rate in Hospitalized Ulcerative Colitis Patients Undergoing Therapy with Cyclosporine (CsA)

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-87-A-87

2009

Volltextzugriff (PDF)

T1127 Adalimumab Safety in Patients with Crohn's Disease and Previous Exposure to Infliximab: CHOICE Trial

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-489-A-489

2008

Volltextzugriff (PDF)

W1232 Bridging Therapy with Cyclosporine and 6mp Significantly Reduces Long-Term Colectomy Rates in Patients with Severe Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-660-A-660

2008

Volltextzugriff (PDF)

T1142 Infliximab Treatment for Ulcerative Colitis: Clinical Response, Clinical Remission, & Mucosal Healing in Patients with Moderate or Severe Disease in the Active Ulcerative Colitis Trials (ACT1 & ACT2)

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-493-A-493

2008

Volltextzugriff (PDF)

T1139 The ACT Trials: Incremental Benefit of Second and Third Induction Doses of Infliximab in Patients with Moderately-to-Severely Active Ulcerative Colitis (UC)

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-492-A-492

2008

Volltextzugriff (PDF)

198 Follow-Up Chromoendoscopy Continues to Be Superior to Standard Colonoscopic Surveillance for Managing Dysplasia in Patients with IBD: A Long-Term, Prospective, Endoscopic Trial

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-34-A-34

2008

Volltextzugriff (PDF)

Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes

Gastroenterology & hepatology, 2009-06, Vol.5 (6 Suppl), p.4-16

2009

Volltextzugriff (PDF)

Management of fistula disease

Inflammatory bowel diseases, 1998-11, Vol.4 (4), p.302-307

Present, Daniel H.

1998

Volltextzugriff (PDF)

M2071 Innate Immune Defects in IRGM1, TLR2, and NOD2 Contribute to Crohn's Disease Risk and Severity in Ashkenazi Jews

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-463-A-463

2008

Volltextzugriff (PDF)

How to do without steroids in inflammatory bowel disease

Inflammatory bowel diseases, 2000-02, Vol.6 (1), p.48-57

Present, Daniel H.

2000

Volltextzugriff (PDF)

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

Annals of internal medicine, 1989-10, Vol.111 (8), p.641

1989

Volltextzugriff (PDF)

Are laboratory tests effective in assessing disease activity in inflammatory bowel disease (IBD)?

The American journal of gastroenterology, 2003-09, Vol.98 (s9), p.S258-S258

2003

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(117)
Bücher
(1)

Sprache

Englisch
(118)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy

T1141 Co-Administration of Certolizumab Pegol with Immunosuppressants and/or Corticosteroids Is Not Associated with An Increased Risk of Adverse Events with Crohn's Disease: Analysis of Pooled Data

488 Early Institution of Tinidazole May Prevent Pouchitis Following Ileal-Pouch Anal Anastomosis (IPAA) Surgery in Ulcerative Colitis (UC) Patients

W1105 Cyclosporine and Infliximab As Delayed Salvage Therapy for Each Other in Patients with Steroid-Refractory Ulcerative Colitis

M1136 The Natural History of Dysplasia in Inflammatory Bowel Disease: Influence of Disease Type and Dysplasia Morphology and Grade On Cancer Risk

Infliximab therapy for ulcerative colitis: many unanswered questions

Preliminary report: cyclosporin in treatment of severe active ulcerative colitis

T1062 Improvement in Work Productivity with Adalimumab in Crohn's Disease Patients Who Failed Prior Infliximab: An Analysis of the CHOICE Trial

T1061 Improvement in Short Inflammatory Bowel Disease Questionnaire Scores in Adalimumab-Treated Crohn's Disease Patients Who Failed Infliximab (CHOICE Trial)

Urinary tract fistulas in Crohn’s disease: surgery versus medical therapy

Alcohol is well tolerated in IBD patients taking either metronidazole or 6-Mercaptopurine

1047 Chromoendoscopy Is Superior to Standard Surveillance Techniques for Both High and Low Risk Patients for the Detection of Dysplasia: Analysis of a Prospective Controlled Trial

558 Outcomes After Retreatment with Cyclosporine a (CsA) in Hospitalized Ulcerative Colitis (UC) Patients: A 7-Year Review from a Single Institution

557 Colectomy Rate in Hospitalized Ulcerative Colitis Patients Undergoing Therapy with Cyclosporine (CsA)

T1127 Adalimumab Safety in Patients with Crohn's Disease and Previous Exposure to Infliximab: CHOICE Trial

W1232 Bridging Therapy with Cyclosporine and 6mp Significantly Reduces Long-Term Colectomy Rates in Patients with Severe Ulcerative Colitis

T1142 Infliximab Treatment for Ulcerative Colitis: Clinical Response, Clinical Remission, & Mucosal Healing in Patients with Moderate or Severe Disease in the Active Ulcerative Colitis Trials (ACT1 & ACT2)

T1139 The ACT Trials: Incremental Benefit of Second and Third Induction Doses of Infliximab in Patients with Moderately-to-Severely Active Ulcerative Colitis (UC)

198 Follow-Up Chromoendoscopy Continues to Be Superior to Standard Colonoscopic Surveillance for Managing Dysplasia in Patients with IBD: A Long-Term, Prospective, Endoscopic Trial

Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes

Management of fistula disease

M2071 Innate Immune Defects in IRGM1, TLR2, and NOD2 Contribute to Crohn's Disease Risk and Severity in Ashkenazi Jews

How to do without steroids in inflammatory bowel disease

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

Are laboratory tests effective in assessing disease activity in inflammatory bowel disease (IBD)?

Aktive Filter

Suchergebnisse filtern